Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKinsey
UBS
Moodys
Fuji
Chubb
Baxter
Queensland Health
Merck

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 081215

« Back to Dashboard

NDA 081215 describes ESTROPIPATE, which is a drug marketed by Barr, Duramed Pharms Barr, Mylan, Watson Labs, and Watson Labs Teva, and is included in seven NDAs. It is available from two suppliers. Additional details are available on the ESTROPIPATE profile page.

The generic ingredient in ESTROPIPATE is estropipate. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the estropipate profile page.
Summary for 081215
Tradename:ESTROPIPATE
Applicant:Watson Labs Teva
Ingredient:estropipate
Patents:0
Therapeutic Class:Hormonal Agents, Stimulant/Replacement/Modifying (Sex Hormones/Modifiers)
Formulation / Manufacturing:see details
Suppliers and Packaging for NDA: 081215
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ESTROPIPATE estropipate TABLET;ORAL 081215 ANDA Actavis Pharma, Inc. 0591-0416 N 0591-0416-30
ESTROPIPATE estropipate TABLET;ORAL 081215 ANDA Actavis Pharma, Inc. 0591-0416 N 0591-0416-05

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength3MG
Approval Date:Sep 23, 1993TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Chubb
Chinese Patent Office
Covington
Cerilliant
Daiichi Sankyo
Cipla
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.